Icl Israel Chemicals Stock Current Valuation
| ICL Stock | USD 4.62 0.18 4.05% |
Valuation analysis of ICL Israel Chemicals helps investors to measure ICL Israel's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The value of Enterprise Value Over EBITDA is expected to slide to 4.96. The value of Enterprise Value Multiple is estimated to slide to 4.96. Fundamental drivers impacting ICL Israel's valuation include:
Price Book 0.9754 | Enterprise Value 7.6 B | Enterprise Value Ebitda 5.8768 | Price Sales 0.8266 | Trailing PE 14.3226 |
Undervalued
Today
Please note that ICL Israel's price fluctuation is slightly risky at this time. Calculation of the real value of ICL Israel Chemicals is based on 3 months time horizon. Increasing ICL Israel's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ICL stock is determined by what a typical buyer is willing to pay for full or partial control of ICL Israel Chemicals. Since ICL Israel is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ICL Stock. However, ICL Israel's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.62 | Real 5.28 | Target 6.59 | Hype 4.62 | Naive 4.52 |
The intrinsic value of ICL Israel's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence ICL Israel's stock price.
Estimating the potential upside or downside of ICL Israel Chemicals helps investors to forecast how ICL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ICL Israel more accurately as focusing exclusively on ICL Israel's fundamentals will not take into account other important factors: ICL Israel Chemicals Company Current Valuation Analysis
ICL Israel's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ICL Israel Current Valuation | 7.61 B |
Most of ICL Israel's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICL Israel Chemicals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ICL Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for ICL Israel is extremely important. It helps to project a fair market value of ICL Stock properly, considering its historical fundamentals such as Current Valuation. Since ICL Israel's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ICL Israel's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ICL Israel's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, ICL Israel Chemicals has a Current Valuation of 7.61 B. This is 33.3% lower than that of the Chemicals sector and 15.21% lower than that of the Materials industry. The current valuation for all United States stocks is 54.22% higher than that of the company.
ICL Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICL Israel's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICL Israel could also be used in its relative valuation, which is a method of valuing ICL Israel by comparing valuation metrics of similar companies.ICL Israel is currently under evaluation in current valuation category among its peers.
ICL Israel ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ICL Israel's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ICL Israel's managers, analysts, and investors.Environmental | Governance | Social |
ICL Fundamentals
| Return On Equity | 0.0776 | |||
| Return On Asset | 0.0418 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 7.61 B | |||
| Shares Outstanding | 1.29 B | |||
| Shares Owned By Insiders | 44.05 % | |||
| Shares Owned By Institutions | 26.45 % | |||
| Number Of Shares Shorted | 1.08 M | |||
| Price To Earning | 918.89 X | |||
| Price To Book | 0.98 X | |||
| Price To Sales | 0.83 X | |||
| Revenue | 7.54 B | |||
| Gross Profit | 5.03 B | |||
| EBITDA | 1.67 B | |||
| Net Income | 647 M | |||
| Cash And Equivalents | 516 M | |||
| Cash Per Share | 0.40 X | |||
| Total Debt | 2.69 B | |||
| Debt To Equity | 0.51 % | |||
| Current Ratio | 1.65 X | |||
| Book Value Per Share | 4.55 X | |||
| Cash Flow From Operations | 1.59 B | |||
| Short Ratio | 1.66 X | |||
| Earnings Per Share | 0.31 X | |||
| Price To Earnings To Growth | 9.44 X | |||
| Target Price | 4.74 | |||
| Number Of Employees | 12 K | |||
| Beta | 1.26 | |||
| Market Capitalization | 5.73 B | |||
| Total Asset | 11.63 B | |||
| Retained Earnings | 5.58 B | |||
| Working Capital | 1.4 B | |||
| Current Asset | 2.98 B | |||
| Current Liabilities | 2.05 B | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.55 % | |||
| Net Asset | 11.63 B | |||
| Last Dividend Paid | 0.2 |
About ICL Israel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICL Israel Chemicals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICL Israel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICL Israel Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ICL Israel Piotroski F Score and ICL Israel Altman Z Score analysis. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.18) | Dividend Share 0.2 | Earnings Share 0.31 | Revenue Per Share 5.373 | Quarterly Revenue Growth (0.06) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.